CD33 and acute lymphoblastic leukemia: While some laboratories have established standard antibody panels with29, 30 or without CD13/CD3331 for MRD measurements, our single‐center experience is to make CD13 and CD33 routine markers for both B‐ALL diagnosis and MRD detection.